The population is expanding. Cities are shooting upwards, and manmade materials now outweigh all life on earth. With big populations come big problems, to which we need big solutions. Enter: Big Science, the answer to some of humanity’s most pressing problems.

Business process transformation is becoming a major focal point for organizations, aiming to improve their operational decision making with data. The digital twin market is aiding in this area with its ability to mirror products and therefore encounter possible errors or insights before they have happened on the original device. The global market for digital twins has already seen remarkable growth, and is expected to hit $50.2 billion by 2026, at a compound annual growth rate of 59.0%.

When we think about data we imagine thousands of pages of codes, letters, numbers; a mass of information that simply exists. The volume of data that organizations must continuously manage and analyze seems to be never-ending and forever growing.

By 2022, robots are well-ingrained into our cultural psyche. A.I already features in many gadget-enthusiasts’ repertoires, with robotic vacuums and virtual assistants being common household appendages. But a fascination with robots isn’t reserved solely for this niche. Fitness fanatics have been maximising workouts with smart wearables, and even bookish types have pondered for decades whether androids dream of electric sheep. One thing is clear: A.I is entrenched deeply into society. And it’s only a matter of time until it completely transforms the world as we know it.

When we look to the future we see a world in chrome, with robots tutoring our children and driving our cars. Of course, in 2022, these predictions aren’t far off, and artificial intelligence (AI) technology has been implemented in most industries in some form or another.

Biotechnology is fundamental to the continued growth and advancement of modern life. With cancer cases rising, the number of genetically occurring diseases increasing, and food production chains threatened by pests and disease, creating biologically engineered solutions to these issues is more crucial than ever.

Whether you refer to it as The Big C, a malignant neoplasm, or its simpler name; cancer, we all know what it is and have all heard and seen the detrimental effect it has on those fighting and living with it every day. With a devastating mortality rate and a plethora of heart-breaking films, podcasts, and charities to remind us why research is so fundamental, cancer is one disease we can’t seem to sweep under the rug. According to Stand Up to Cancer (SU2C) UK, one in two of us will get cancer in our lifetime which, as a harrowing statistic in itself, means that funding cancer research and the development of potential cures is vital.

Industry 4.0 embraces a new era of interconnected technologies. While the first industrial revolution saw the rise of steam power and mechanisation on a mass scale, the fourth industrial revolution or Industry 4.0, anticipates a mass cyber-physical overhaul.

Imagine being able to curate specific, complex collections of cells that directly resemble an individual patient's own tissues? Imagine no more... This technology has already been developed and is gaining steady traction across the market, alongside traditional ways of studying diseases outside of the body. Organoids, 3D cultures and laboratory animals have, and will continue, play a vital role in the way medicine works, as well as how doctors treat us as patients.